KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Merck (MRK) Consolidated Net Income (2016 - 2026)

Merck has reported Consolidated Net Income over the past 17 years, most recently at -$4.2 billion for Q1 2026.

  • Quarterly Consolidated Net Income fell 182.77% to -$4.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $9.0 billion through Mar 2026, down 48.61% year-over-year, with the annual reading at $18.3 billion for FY2025, 6.6% up from the prior year.
  • Consolidated Net Income was -$4.2 billion for Q1 2026 at Merck, down from $3.0 billion in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $5.8 billion in Q3 2025 and troughed at -$5.9 billion in Q2 2023.
  • The 4-year median for Consolidated Net Income is $3.7 billion (2024), against an average of $2.4 billion.
  • Year-over-year, Consolidated Net Income soared 405.38% in 2024 and then tumbled 182.77% in 2026.
  • A 4-year view of Consolidated Net Income shows it stood at -$1.2 billion in 2023, then soared by 405.38% to $3.7 billion in 2024, then decreased by 20.89% to $3.0 billion in 2025, then tumbled by 242.1% to -$4.2 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Consolidated Net Income are -$4.2 billion (Q1 2026), $3.0 billion (Q4 2025), and $5.8 billion (Q3 2025).